Robin H. van der weide
banner
robinhweide.bsky.social
Robin H. van der weide
@robinhweide.bsky.social
Quantitative Chromatin Biology

Postdoctoral fellow single-cell multimodal epigenomics @ Jop Kind / Hubrecht Institute
Reposted by Robin H. van der weide
A new and fascinating story from @bencarty.bsky.social and the group, with crucial help from the teams of @naltemose.bsky.social, Simona Giunta, and @dfachinetti.bsky.social. Many thanks to all for a fantastic collaboration.
www.nature.com/articles/s41...
November 25, 2025 at 12:16 PM
Reposted by Robin H. van der weide
Introducing bluffbench, a new tool to evaluate how well LLMs actually see data plots.

When we trick LLMs with secret #RStats transformations, they can miss the visual contradiction.

bluffbench helps us measure this "blind spot" in AI coding agents. Learn more: posit.co/blog/introdu...
When plotting, LLMs see what they expect to see - Posit
Data science agents need to accurately read plots even when the content contradicts their expectations. Our testing shows today's LLMs still struggle here.
posit.co
November 19, 2025 at 4:55 PM
Reposted by Robin H. van der weide
periodic reminder of the existence of Atkinson Hyperlegible, a free font available from the Braille Institute designed to improve readability for people with low vision

I use it in talks because it's pretty and also because, as an audience member, I am perpetually squinting at people's slides
Atkinson Hyperlegible Font - Braille Institute
Read easier with Atkinson Hyperlegible Font, crafted for low-vision readers. Download for free and enjoy clear letters and numbers on your computer!
www.brailleinstitute.org
November 17, 2025 at 4:19 AM
I need a reference manager that's amazing for both organizing and reading on a laptop & tablet. 📑

It's a showdown: Paperpile vs. ReadCube Papers. What's your go-to and why?

#Academia #Paperpile #ReadCube
August 21, 2025 at 2:57 PM
Reposted by Robin H. van der weide
Agony aunt 🖋️ A cancer researcher is suspicious about a paper they’ve been asked to review. What steps should they take?

go.nature.com/3UhImt0
Should I tell anyone that I suspect misconduct in a paper I’m reviewing?
A cancer researcher is suspicious about a paper they’ve been asked to review. What steps should they take?
go.nature.com
July 18, 2025 at 11:34 AM
Reposted by Robin H. van der weide
We found a new asymmetry in the large-scale chromosome structure: sister chromatids are systematically shifted by hundreds of kb in the 5′→3′ direction of their inherited strands! The work was led by Flavia Corsi, in close collaboration with the Daniel Gerlich lab.
www.biorxiv.org/content/10.1...
1/
July 15, 2025 at 8:11 AM
Reposted by Robin H. van der weide
🚨 Preprint 🚨
Ever wondered how cells prepare their genomes to enable new cell-fates? In this team up with the Kind lab, we show that genes are repositioned in the nucleus to get ready for future activation and tissue formation. Read 🧵👇 to find out how and when this happens!

doi.org/10.1101/2025...
Reconfiguration of genome-lamina interactions marks the commissioning of limb cell-fates
Diverse forms of heterochromatin block inappropriate transcription and safeguard differentiation and cell identity. Yet, how and when heterochromatin is reconfigured to facilitate changes in cell-fate...
www.biorxiv.org
May 8, 2025 at 9:43 AM
Reposted by Robin H. van der weide
🚨 Preprint alert 🚨
Excited to share our work on "Ab-trapping," an antibody artifact causing misleading peripheral ("rim") staining in imaging & genomics (IF, CUT&Tag, CUT&RUN). Antibodies fail to penetrate structures, accumulating at the periphery. A 🧵👇
doi.org/10.1101/2025...
Ab-trapping - a peripheral staining artifact in antibody-based microscopy and genomics
Antibodies (Ab) are essential for detecting specific epitopes in microscopy and genomics, but can produce artifacts leading to erroneous interpretations. Here, we characterize a novel artifact, Ab-tra...
doi.org
April 14, 2025 at 8:08 PM
Reposted by Robin H. van der weide
Our ChromBPNet preprint out!

www.biorxiv.org/content/10.1...

Huge congrats to Anusri! This was quite a slog (for both of us) but we r very proud of this one! It is a long read but worth it IMHO. Methods r in the supp. materials. Bluetorial coming soon below 1/
December 25, 2024 at 11:48 PM
Reposted by Robin H. van der weide
1/🚀 Excited to share RegVelo, our new cell model combining RNA velocity with gene regulatory network (GRN) dynamics to model cellular changes and predict in silico perturbations. Here's how it works and why it matters! 🧵👇
biorxiv.org/content/10.1101/2024.12.11.627935v1
December 12, 2024 at 2:48 PM
Reposted by Robin H. van der weide
Very excited to see our work on genome-wide mapping DNA repair in single cells out @naturecomms.bsky.social
Amazing work by Kim de Luca & Pim Rullens. Wonderful collaboration with the Legube lab, @mariekeoudelaar.bsky.social & @jjachowicz.bsky.social . rdcu.be/d0ZAM
November 27, 2024 at 11:45 AM
Reposted by Robin H. van der weide
1. You have limited time to make scientific contributions. Do the big things
2.Go back and forth between day and night science
3. Give adequate attention to the thinking and analysis aspects of research
4. Do your go-no-go experiments early on to avoid wasting time
5. Face risk early

And more 👇🏾
The goal is not to have a zero risk project; those are generally not worth working on. People with a good relationship with risk are definitely not avoiding it. They are super honest about it and they basically make it their goal to slowly chip away at it.
nightscience.buzzsprout.com/1744020/epis...
66 | Michael Fischbach and the scientific decision tree - Night Science
In this episode, Stanford professor Michael Fischbach discusses insights from his course on how to choose meaningful research problems. Highlights include:- Invest time in problem selection: Spend mor...
nightscience.buzzsprout.com
November 25, 2024 at 7:37 PM
Reposted by Robin H. van der weide
I used to have imposter syndrome. I don't any more. At some point I came to terms with the fact that I'm really an imposter. I'm totally ok with it & simply decided to do my best with the opportunities that presented themselves to me, until my luck runs out. It's surprisingly effective.
70% of scientists say they experience the imposter syndrome. I still experience it too sometimes, and what helps is talking with a science buddy with whom it’s ok to say stupid things, which may actually turn out to be good ideas.
November 24, 2024 at 4:52 AM
Reposted by Robin H. van der weide
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:

docs.bsky.app/docs/advance...

#AcademicSky #HigherEd #Altmetrics
Action Intent Links | Bluesky
Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...
docs.bsky.app
November 18, 2024 at 2:48 PM
Reposted by Robin H. van der weide
Doing good science is 90% finding a science buddy to constantly talk to about the project.
November 9, 2024 at 10:53 PM